BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, March 2, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements for March 5, 2020

March 5, 2020
New hires and promotions in the med-tech industry, including: Aspen Surgical Products, Cognoa, Dariohealth, Electromed, Neuronetics.
Read More

Regulatory actions for March 5, 2020

March 5, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allergan, Cardiol, Outlook, TG, Urovant, Zydus.
Read More

Other news to note for March 5, 2020

March 5, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allogene, Cellectis, City of Hope, Eleusis, Melinta, Scynexis, Servier.
Read More

In the clinic for March 5, 2020

March 5, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Actinium, Arch, Auris, Debiopharm, Dynacure, Psioxus.
Read More

Financings for March 5, 2020

March 5, 2020
Biopharmas raising money in public or private financings, including: Baudax, Enlivex, Titan.
Read More

Appointments and advancements for March 5, 2020

March 5, 2020
New hires and promotions in the biopharma industry, including: Alligator, Fusion, Matinas, Rapt, Windmil.
Read More

Appointments and advancements for March 4, 2020

March 4, 2020
New hires and promotions in the med-tech industry, including: Anika Therapeutics, Charles River Laboratories International, Citiustech.
Read More

Regulatory actions for March 4, 2020

March 4, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Roche.
Read More

In the clinic for March 4, 2020

March 4, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Inflammatix, Ocutrx Vision Technologies.
Read More

Other news to note for March 4, 2020

March 4, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allscripts, Biogen, Celgene, Emovi, Genentech, Haliodx, Immunxperts, Kabafusion, Lincare, Luminex, Lung Therapeutics, Macopharma, Mahajan Imaging, Medical 2011, Medx Health, Mesa Biotech, Nexelis, Optikira, Orthopediatrics, Pixium Vision, Pliant Therapeutics, Respivant Sciences, SymphonyAI, SyntheticMR, Terarecon, Veradigm.
Read More
Previous 1 2 … 1637 1638 1639 1640 1641 1642 1643 1644 1645 … 1760 1761 Next

Popular Stories

  • Today's news in brief

    BioWorld
  • Brain and virus with chromosome

    CROI 2026: Neurodegeneration, the challenge of aging with HIV

    BioWorld
    Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for Feb. 24, 2026
  • Depression concept with human, broken brain and heavy rain

    CROI 2026 highlights depression and cognitive vulnerability in HIV

    BioWorld
    The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
  • Concept art for headache

    Slate Medicines launches with focus on headache disorders

    BioWorld Science
    Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing